
|Articles|August 1, 2002
The American Journal of Managed Care
- August 2002
- Volume 8
- Issue 8
The Comparative Clinical and Economic Benefits of Drugs Should be Established and Discussed as Part of any Formulary Decision Process
Advertisement
Articles in this issue
over 23 years ago
A New Era of Leadershipover 23 years ago
The Potential of Pill Splitting to Achieve Cost Savingsover 23 years ago
Rational Use of Antibiotics to Treat Respiratory Tract Infectionsover 23 years ago
Reducing Cesarean Delivery Rates in Managed Care OrganizationsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Discontinuation of ACA Subsidies Will Leave Many Uninsured: Ciara Zachary, PhD, MPH
2
KYV-101 Achieves Durable Response in Myasthenia Gravis
3
How Artificial Intelligence Is Transforming Leukemia Detection and Diagnosis
4
ncRNAs Linked to CLL Outcomes, Meta-Analysis Finds
5













































